Singapore markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
146.97-2.73 (-1.82%)
At close: 04:00PM EDT
147.01 +0.04 (+0.03%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close149.70
Open149.53
Bid146.91 x 1100
Ask147.00 x 1200
Day's range146.76 - 149.81
52-week range143.13 - 175.97
Volume9,520,576
Avg. volume7,496,114
Market cap353.71B
Beta (5Y monthly)0.55
PE ratio (TTM)21.84
EPS (TTM)6.73
Earnings date17 Jul 2024
Forward dividend & yield4.96 (3.37%)
Ex-dividend date20 May 2024
1y target est172.72
  • Zacks

    Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know

    In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $146.97, denoting a -1.82% change from the preceding trading day.

  • Insider Monkey

    Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?

    In this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded healthcare company? If you wish to learn about more companies, head straight to the Top 20 Largest Publicly Traded Healthcare Companies. Major Players Driving the U.S. Healthcare Industry’s Growth and Innovation The global healthcare industry is […]

  • Reuters

    Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies

    A group of cancer victims sued Johnson & Johnson on Wednesday, accusing the healthcare company of committing fraud through repeated and continued efforts to use a shell company's bankruptcy to resolve tens of thousands of lawsuits alleging its talc products contained asbestos and caused cancer. Five plaintiffs who seek to represent over 50,000 people who have sued J&J over its talc products filed the proposed class action in New Jersey federal court. "Johnson & Johnson is playing a dark game of chess with this country's financial and judicial systems," said Mike Papantonio, an attorney for the cancer plaintiffs.